The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
Open accessAbstract
PurposeResveratrol (3,5,4′-trihydroxy-trans-stilbene) is a naturally occurring polyphenol with a broad range of possible health benefits, including anti-cancer activity. However, the biological activity of resveratrol may be limited by poor absorption and first-pass metabolism: only low plasma concentrations of resveratrol are seen following oral administration, and metabolism to glucuronide and sulfate conjugates is rapid. Methylated polyphenol analogs (such as pterostilbene [3,5-dimethoxy-4′-hydroxy-trans-stilbene], the dimethylether analog of resveratrol) may overcome these limitations to pharmacologic efficacy. The present study was designed to compare the bioavailability, pharmacokinetics, and metabolism of resveratrol and pterostilbene following equimolar oral dosing in rats.MethodsThe agents were administered orally via gavage for 14 consecutive days at 50 or 150 mg/kg/day for resveratrol and 56 or 168 mg/kg/day for pterostilbene. Two additional groups were dosed once intravenously with 10 and 11.2 mg/kg for resveratrol and pterostilbene, respectively. Plasma concentrations of agents and metabolites were measured using a high-pressure liquid chromatograph-tandem mass spectrometer system. Noncompartmental analysis was used to derive pharmacokinetic parameters.ResultsResveratrol and pterostilbene were approximately 20 and 80% bioavailable, respectively. Following oral dosing, plasma levels of pterostilbene and pterostilbene sulfate were markedly greater than were plasma levels of resveratrol and resveratrol sulfate. Although plasma levels of resveratrol glucuronide exceeded those of pterostilbene glucuronide, those differences were smaller than those of the parent drugs and sulfate metabolites.ConclusionsWhen administered orally, pterostilbene demonstrates greater bioavailability and total plasma levels of both the parent compound and metabolites than does resveratrol. These differences in agent pharmacokinetics suggest that the in vivo biological activity of equimolar doses of pterostilbene may be greater than that of resveratrol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“[17] reported that resveratrol has a number of biological activities that are consistent with cancer chemoprevention and that the agent can inhibit carcinogenesis in experimental animals.”
BackgroundTherapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Resveratrol: A review of preclinical studies for human cancer prevention
ATHAR, M., BACK, J., TANG, X., KIM, K., KOPELOVICH, L., BICKERS, D., & KIM, A. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.025 · Cited by 731
Human Sulfotransferases and Their Role in Chemical Metabolism
Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj061 · Cited by 703
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 688
Metabolism and bioavailability oftrans-resveratrol
Wenzel, E., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500010 · Cited by 676
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Bishayee, A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0160 · Cited by 528
Marier, J.-F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J.-P., & Ducharme, M. P. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033340 · Cited by 480
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Kundu, J. K., & Surh, Y.-J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 473
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms
Athar, M., Back, J. H., Kopelovich, L., Bickers, D. R., & Kim, A. L. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.018 · Cited by 462
Saiko, P., Szakmary, A., Jaeger, W., & Szekeres, T. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.08.004 · Cited by 442
Resveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 405
Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability
Wen, X., & Walle, T. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011122 · Cited by 377
Resveratrol: One molecule, many targets
Pirola, L., & Fröjdö, S. (2008) · IUBMB Life · doi:10.1002/iub.47 · Cited by 347
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Shankar, S. (2007) · Frontiers in Bioscience · doi:10.2741/2432 · Cited by 342
Langcake, P. (1981) · Physiological Plant Pathology · doi:10.1016/s0048-4059(81)80043-4 · Cited by 304
Rimando, A. M., Cuendet, M., Desmarchelier, C., Mehta, R. G., Pezzuto, J. M., & Duke, S. O. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0116855 · Cited by 295
la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., & Cameron, D. W. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531820-000000000-00000 · Cited by 261
Resveratrol in Cardioprotection: A Therapeutic Promise of Alternative Medicine
Das, D. K. (2006) · Molecular Interventions · doi:10.1124/mi.6.1.7 · Cited by 258
Resveratrol Is Absorbed in the Small Intestine as Resveratrol Glucuronide
Kuhnle, G., Spencer, J. P. E., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K. S., Rice-Evans, C., & Hahn, U. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2750 · Cited by 249
Bioactivity and metabolism oftrans-resveratrol orally administered to Wistar rats
Wenzel, E., Soldo, T., Erbersdobler, H., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500003 · Cited by 236
Schmidlin, L., Poutaraud, A., Claudel, P., Mestre, P., Prado, E., Santos-Rosa, M., Wiedemann-Merdinoglu, S., Karst, F., Merdinoglu, D., & Hugueney, P. (2008) · Plant Physiology · doi:10.1104/pp.108.126003 · Cited by 210
Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
Hoshino, J., Park, E.-J., Kondratyuk, T. P., Marler, L., Pezzuto, J. M., van Breemen, R. B., Mo, S., Li, Y., & Cushman, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100274c · Cited by 202
The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol
Das, S., Lin, H.-S., Ho, P. C., & Ng, K.-Y. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9677-1 · Cited by 201
Lin, H., Yue, B., & Ho, P. C. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1254 · Cited by 190
Pleiotropic mechanisms facilitated by resveratrol and its metabolites
Calamini, B., Ratia, K., Malkowski, M. G., Cuendet, M., Pezzuto, J. M., Santarsiero, B. D., & Mesecar, A. D. (2010) · Biochemical Journal · doi:10.1042/bj20091857 · Cited by 175
Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review)
Brisdelli, F., D'Andrea, G., & Bozzi, A. (2009) · Current Drug Metabolism · doi:10.2174/138920009789375423 · Cited by 168
Marques, F. Z., Markus, M. A., & Morris, B. J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.06.003 · Cited by 163
Paul, S., Rimando, A. M., Lee, H. J., Ji, Y., Reddy, B. S., & Suh, N. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0224 · Cited by 160
Resveratrol and chemoprevention
Goswami, S. K., & Das, D. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.041 · Cited by 151
Suh, N., Paul, S., Hao, X., Simi, B., Xiao, H., Rimando, A. M., & Reddy, B. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1528 · Cited by 151
Chakraborty, A., Gupta, N., Ghosh, K., & Roy, P. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.02.007 · Cited by 139
van de Wetering, K., Burkon, A., Feddema, W., Bot, A. G. M., de Jonge, H. R., Somoza, V., & Borst, P. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052019 · Cited by 138
Resveratrol as an Inhibitor of Carcinogenesis
Pezzuto, J. M. (2008) · Pharmaceutical Biology · doi:10.1080/13880200802116610 · Cited by 136
Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol
Kraft, T. E., Parisotto, D. A., Schempp, C. M., & Efferth, T. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802248627 · Cited by 134
Paul, S., DeCastro, A., Lee, H. J., Smolarek, A. K., So, J. Y., Simi, B., Wang, C.-X., Zhou, R., Rimando, A. M., & Suh, N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq004 · Cited by 130
Distribution of [3H]trans-resveratrol in rat tissues following oral administration
El-Mohsen, M. A., Bayele, H. K., Kuhnle, G., Gibson, G., Debnam, E. S., Srai, S. K., Rice-Evans, C. A., & Spencer, J. P. E. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061810 · Cited by 128
Santi, C. D., Pietrabissa, A., Spisni, R., Mosca, F., & Pacifici, G. M. (2000) · Xenobiotica · doi:10.1080/004982500406435 · Cited by 115
Biological/Chemopreventive Activity of Stilbenes and their Effect on Colon Cancer
Rimando, A. M., & Suh, N. (2008) · Planta Medica · doi:10.1055/s-0028-1088301 · Cited by 107
Pan, Z., Agarwal, A. K., Xu, T., Feng, Q. F., Baerson, S. R., Duke, S. O., & Rimando, A. M. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-7 · Cited by 62
Pterostilbene Inhibits Pancreatic Cancer In Vitro
Mannal, P. W., Alosi, J. A., Schneider, J. G., McDonald, D. E., & McFadden, D. W. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1164-4 · Cited by 54
Cited by
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,334
Administration of resveratrol: What formulation solutions to bioavailability limitations?
Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 620
Resveratrol for cancer therapy: Challenges and future perspectives
Ren, B., Kwah, M. X.-Y., Liu, C., Ma, Z., Shanmugam, M. K., Ding, L., Xiang, X., Ho, P. C.-L., Wang, L., Ong, P. S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.001 · Cited by 495
Biological Activities of Stilbenoids
Akinwumi, B., Bordun, K.-A., & Anderson, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030792 · Cited by 373
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
Zahin, N., Anwar, R., Tewari, D., Kabir, M. T., Sajid, A., Mathew, B., Uddin, M. S., Aleya, L., & Abdel-Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05211-0 · Cited by 371
Metadata
- Authors
- Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N., & McCormick, D. L.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2010-11-30
- Volume
- 68
- Issue
- 3
- Pages
- 593-601
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W2082410007
- Cited by
- 609
- References
- 45
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.